PetMed Express is the original online pet pharmacy in the United States, and the franchise that once funded dividends is now a shrinking prescription book sitting under an unsolicited cash bid the board has not accepted. SilverCape Investments, a Singapore family office that already holds a double-digit stake, cut its December proposal after the March-year collapse and returned with a $3 cash price. The market is not treating that bid as a floor. The live debate is whether the board runs a real sale process before liquidity, not brand memory, decides the outcome.
Year-over-year sales are still falling because prescription fills, the high-intent product that built the brand, keep leaking to Chewy, Amazon, and clinic channels. Net sales declined 20 percent in the June quarter as prescription medication volume kept shrinking. Management calls the last several quarters stabilization because the top line has stopped collapsing sequentially and AutoShip plus membership, the automatic-refill and paid-club programs, now account for a larger share of sales. That mix shift is real. It is also the signature of a smaller, stickier book, not a returning growth engine. The GAAP loss narrowed mainly because last year's PetCareRx goodwill write-off did not repeat, while the company's preferred operating score, adjusted earnings before interest, taxes, depreciation, and amortization, got worse.
Cash fell to $13 million at quarter-end, with a working-capital deficit and no funded bank debt. The board's answer is a $37 million sale-leaseback of the Delray Beach campus, a Rural King white-label pharmacy launch, and an open chief-executive search. Whether those moves fund a standalone repair, or merely extend the clock on a bid the tape already discounts, is the question the next two quarters resolve.